Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04992026Phase 2Completed
The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
AbirateroneOligometastatic Prostate CancerProstatectomy
PrincipalinvestigatorStart date: 2021-01-01
NCT04356430Phase 2Unknown
Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer
Prostate Cancer
PrincipalinvestigatorStart date: 2019-04-01
NCT04869371Phase 2Unknown
Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer
Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
PrincipalinvestigatorStart date: 2018-12-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Nanjing Drum Tower Hospital, affiliated to medical school of Nanjing University

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04992026Phase 2PrincipalInvestigator

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

AbirateroneOligometastatic Prostate CancerProstatectomy
Completed
NCT04356430Phase 2PrincipalInvestigator

Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer

Prostate Cancer
Unknown
NCT04869371Phase 2PrincipalInvestigator

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
Unknown

All 3 trials loaded